In a previous study, where patients with all immunohistochemical subtypes of BC were investigated for the existence of a germline PV in BRCA1/2, it was observed that BRCA1/2 carriers were more prone to develop CNS metastasis compared to patients that did not carry PVs in these genes (noncarriers).17 The gene discussed is BRCA1; the disease is breast cancer.